A Systematic Review and Meta-analysis
Clinical Infectious Diseases® 2016;62(12):1586–94
Le Bénin est un pays à épidémie mixte car il existe des poches de concentration de fortes prévalences
au sein de certaines populations clés plus exposées aux risques d’infection, notamment les TS et
leurs partenaires, les prisonniers, les HSH et les UDI. Les sections suivantes présentero...nt la
prévalence dans les différents groupes.
more
National Guidelines for HIV & AIDS Care and Treatment (5th Edition)
This case study explores how the Talent Youth Association, supported by Link Up, promotes the integration of comprehensive sexuality education in school curricula in Ethiopia in order to enable young people to understand and claim their sexual and reproductive health and rights
Editorial
Rev Panam Salud Publica 40(6), 2016
A practioner's guide, based on lessons from Ebola.
This guide is a compilation of best practices and key lessons learned through Oxfam’s experience of community engagement during the 2014–15 Ebola response in Sierra Leone and Liberia. It aims to inform public health practitioners and programme ...teams about the design and implementation of community-centred approaches
more
Overview
Rev Panam Salud Publica 40(6), 2016
District hospital level Severe | Malaria is a Medical Emergency
UNAIDS 2016 / Meeting Report
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the population. To fulfill its mandate, DPMED aims to stre...ngthen its regulatory capacity, including the issuance of licenses to pharmaceutical establishments and the registration of pharmaceutical products. Benin’s current registration system shares core concerns that are common to most developing countries, notably the capacity to evaluate and monitor the security, efficacy, and quality of medicines and other health products. It is currently characterized by 1) poor or inadequate traceability of records or regulations (example: a product’s marketing authorization [MA] is often hard to find); 2) lack of evidence used in the regulatory decision-making process (reasons behind special import authorization, i.e., products without valid MAs); 3) inconsistent and unsecured archiving system; 4) limited human resources; and 5) an inefficient information management system
more
НА ПУТИ К ЛИКВИДАЦИИ СПИДА
ИЮНЬ 2016 Г.
PQDx 0033-013-00 WHO
PQ Public Report
July/2016, version 5.0
PQDx 0053-006-00 WHO
PQ Public Report
June/2016, version 2.0
Chapit avanse nan nouvo edisyon an. Creole edition of "Where there is no doctor"
Anba se chapit avanse nan liv Hesperian la: Nouvo Kote ki pa gen doktè. Nou pral ajoute plis chapit lè yo devlope ak tradwi. Aprann plis de revizyon majè ki plis itilize.